kodiak sciences stock zacks

Is a clinical stage biopharmaceutical company engaged in developing novel therapeutics to treat chronic high. The company reported a loss of 98.

Kodiak Sciences Stock Nasdaq Kod Quotes And News Summary Benzinga

KOD Complete Kodiak Sciences Inc.

. According to analysts consensus price target of 3622 Kodiak Sciences has a forecasted upside of 4167 from its current price of 701. Is a clinical stage biopharmaceutical company engaged in developing novel therapeutics to treat chronic high-prevalence retinal diseases which are the. Palo Alto CA-based Kodiak Sciences Inc.

KOD Quick Quote KOD - Free Report reported second-quarter 2022 loss per share of 174 narrower than the Zacks Consensus Estimate of a loss of 177. More Zacks News for KOD Company Summary Kodiak Sciences Inc. The company was formerly known.

Kodiak Sciences Inc. Kodiak Sciences stock loses more than three-quarters of its value after disappointing drug trial results. Kodiak Sciences Inc.

KOD reported first-quarter 2022 loss per share of 183 wider than the Zacks Consensus Estimate of a loss of 139. Currently has a Zacks Rank of 2 Buy. 26 2022 at 134 pm.

View real-time stock prices and stock quotes for a full financial overview. Amount of Analyst Coverage. Kodiak Sciences Inc.

Our research shows that stocks rated Zacks Rank 1 Strong Buy and 2 Buy and Style Scores of A or B. Stock news by MarketWatch.

Kodiak Sciences Inc Kod Stock Price Quote News Stock Analysis